We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Heparin Treatment of Giant Hemangioma With Thrombocytopenia

David L. Benninghoff, MD; Leslie L. Alexander, MD; Mortimer M. Camiel, MD
JAMA. 1968;204(7):635. doi:10.1001/jama.1968.03140200075033.
Text Size: A A A
Published online


To the Editor:—  The report of Drs. Richardson and Smith (203:518, 1968) of successful heparin sodium therapy for a pregnant woman with thrombotic thrombocytopenia purpura (TTP) prompts this letter, suggesting the feasibility of heparin therapy for a different thrombocytopenic syndrome. Thrombocytopenia is an uncommon, but serious, sometimes lethal complication of giant hemangiomas of infancy. Since hemangiomas are malformations that as a rule involute spontaneously, no treatment is indicated. However, when thrombocytopenia or other deficits of coagulation factors occur, active treatment is required, consisting of local radiation, which usually results in rapid clinical improvement and eventual restoration of blood coagulation factors.Irradiation of infants is always cause for concern, however, so that alternative treatments ought to be weighed. Heparin therapy is promising for two reasons: (1) Heparin has been proven effective for the microangiopathies of which TTP is an example.1 (2) Giant hemangioma-thrombocytopenia syndrome may also be considered one


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.